Skip to main content
. 2018 Feb 14;10(2):212. doi: 10.3390/nu10020212

Table 3.

Proportion and conditional logistic regression for higher dietary nutrient intake than recommended in cancer survivors and non-cancer individuals with comorbidities (non-cancer II) compared with non-cancer individuals without comorbidities (non-cancer I).

Nutrient Higher Dietary Nutrient Intake Than Recommended Level, N (%) Odds Ratio a (95% Confidence Interval (CI)) p-Value b
Non-Cancer I (N = 19,926) Non-Cancer II (N = 20,622) Cancer Survivors (N = 5224) Non-Cancer I Non-Cancer II Cancer Survivors
Total energy 6392 (32.1) 6438 (31.2) 1608 (30.8) Reference 0.93 (0.89–0.98) 0.92 (0.86–0.99) 0.81
Carbohydrate (% of total energy) 16901 (84.8) 17649 (85.6) 4585 (87.8) 1.01 (0.96–1.08) 1.21 (1.10–1.33) <0.001
Fat (% of total energy) 203 (1.0) 184 (0.9) 26 (0.5) 0.90 (0.73–1.13) 0.54 (0.35–0.83) 0.02
Protein 11117 (55.8) 11046 (53.6) 2696 (51.6) 0.90 (0.86–0.94) 0.85 (0.79–0.90) 0.05
Vitamin A 4429 (22.2) 4459 (21.6) 1207 (23.1) 0.94 (0.89–0.99) 1.02 (0.95–1.11) 0.02
Vitamin B1 5871 (29.5) 5670 (27.5) 1349 (25.8) 0.92 (0.88–0.97) 0.86 (0.80–0.93) 0.08
Vitamin B2 3395 (17.0) 3290 (16.0) 802 (15.4) 0.94 (0.89–1.00) 0.89 (0.81–0.97) 0.22
Niacin, mg 8206 (41.2) 7893 (38.3) 1976 (37.8) 0.90 (0.87–0.94) 0.91 (0.85–0.97) 0.75
Folate 1575 (7.9) 1535 (7.4) 441 (8.4) 0.93 (0.86–1.01) 1.05 (0.93–1.18) 0.04
Vitamin B6 10627 (53.3) 10624 (51.5) 2775 (53.1) 0.93 (0.89–0.97) 1.01 (0.96–1.08) 0.01
Vitamin C 9156 (46.0) 9347 (45.3) 2589 (49.6) 0.98 (0.94–1.03) 1.16 (1.08–1.23) <0.001
Calcium 2162 (10.9) 2033 (9.9) 564 (10.8) 0.89 (0.83–0.96) 0.96 (0.87–1.07) 0.15
Phosphorus 13873 (69.6) 13802 (66.9) 3434 (65.7) 0.89 (0.86–0.94) 0.86 (0.81–0.92) 0.22
Iron 9019 (45.3) 9579 (46.5) 2504 (47.9) 0.98 (0.94–1.03) 1.05 (0.98–1.13) 0.045
Zinc 8714 (43.7) 8823 (42.8) 2233 (42.7) 0.94 (0.90–0.98) 0.96 (0.89–1.02) 0.65

a Analyses were adjusted for age, marital status, education level, income level, job status, smoking status, drinking status, current physical activity, and body mass index; b Differences between non-cancer individuals with comorbidities and cancer survivors in the Wald test.